Zobrazeno 1 - 10
of 53
pro vyhledávání: '"M. O. Vilain"'
Autor:
Yves-Marie Robin, Sylvia Giard, M.-O. Vilain, Jacques Bonneterre, M.-P. Chauvet, J.-L. Houpeau, Charles Andre, M. C. Baranzelli, I. Farre
Publikováno v:
Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 40:297-304
Journal de Gynecologie Obstetrique et Biologie de la Reproduction - Vol. 40 - N° 4 - p. 297-304
Autor:
M.-O. Vilain, C. Fournier, Luc Vanseymortier, J. Grosjean, C. Leclercq, Luc Ceugnart, D. Pasquier, N. Penel
Publikováno v:
La Revue de Médecine Interne. 25:866-871
Resume Propos. – L’objectif de cette etude est la description de 12 cas recents de sarcomes des tissus mous en territoire irradie avec analyse de survie. Methode. – Il s’agit d’une etude retrospective monocentrique. Les 12 cas sont apparies
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 131:579-582
Resume Introduction Le carcinome neuroendocrine cutane ou tumeur de Merkel est une tumeur dont l’evolution est en general rapide. La taille au moment du diagnostic est en moyenne de 2 a 3 centimetres. Nous rapportons une observation de presentation
Autor:
S. Taieb, E. Dansin, C. Fournier, E. Lartigau, N. Penel, L. Ceugnart, Porte H, M.-O. Vilain, A Wurtz
Publikováno v:
Annales de Chirurgie. 128:237-245
Resume But de l’etude. – Les sarcomes des tissus mous thoraciques regroupent les sarcomes parietaux, pulmonaires et mediastinaux. Il s’agit de tumeurs rares pour lesquelles les indications therapeutiques et les facteurs pronostiques sont mal co
Autor:
C Rigaud, V Le Doussal, Jérôme Couturier, Jocelyne Jacquemier, Gaëtan MacGrogan, Anne Vincent-Salomon, Isabelle Treilleux, S Mathoulin-Pélissier, M-O Vilain, Frédérique Penault-Llorca, Laurent Arnould, Yves Denoux, M-C Mathieu, M Fiche, P Roger
Publikováno v:
Histopathology. 42:337-347
Aims: HER2 protein is over-expressed in 15–30% of breast carcinomas. Immunohistochemistry (IHC) is a common and inexpensive method able to specifically detect HER2 protein. However, lack of standardization of IHC has been considered responsible for
Autor:
J-L, Houpeau, M-C, Baranzelli, S, Giard, M-P, Chauvet, Y-M, Robin, I, Farre, C, Andre, M-O, Vilain, J, Bonneterre
Publikováno v:
Journal de gynecologie, obstetrique et biologie de la reproduction. 40(4)
Intraoperative molecular assay Gene Search BLN Assay (BLN) detects sentinel lymph node (SLN) metastasis in breast cancer. Our objective was to compare BLN to the definitive conventional histologic methods and to experiment the management of BLN in ro
Publikováno v:
Annales de dermatologie et de venereologie. 131(6-7 Pt 1)
Primitive cutaneous neuroendocrine carcinoma or Merkel cell carcinoma is a tumor characterized by rapid evolution. The size at the time of diagnosis is a mean of 2 to 3 centimeters. We report a case of a particular clinical and anatomopathological pr
Autor:
N, Penel, E, Lartigau, C, Fournier, M-O, Vilain, E, Dansin, S, Taieb, L, Ceugnart, H, Porte, A, Wurtz
Publikováno v:
Annales de chirurgie. 128(4)
Primary thoracic soft tissue sarcomas (PTSTS) include parietal, pulmonary and mediastinal tumors. Management and prognostic factors of these rare tumors are poorly known. The aim of the study was to report a series of 40 patients with PTSTS, with ana
Autor:
A, Vincent-Salomon, G, MacGrogan, J, Couturier, L, Arnould, Y, Denoux, M, Fiche, J, Jacquemier, M-C, Mathieu, F, Penault-Llorca, C, Rigaud, P, Roger, I, Treilleux, M-O, Vilain, S, Mathoulin-Pélissier, V, Le Doussal
Publikováno v:
Histopathology. 42(4)
HER2 protein is over-expressed in 15-30% of breast carcinomas. Immunohistochemistry (IHC) is a common and inexpensive method able to specifically detect HER2 protein. However, lack of standardization of IHC has been considered responsible for discrep
Autor:
M O Vilain, Anne Vincent-Salomon, Laurent Arnould, Jérôme Couturier, Frédérique Penault-Llorca, Gaëtan MacGrogan, M. C. Mathieu, Isabelle Treilleux, Yves Denoux, M Fiche
Publikováno v:
British Journal of Cancer, vol. 88, no. 10, pp. 1587-1591
British Journal of Cancer
British Journal of Cancer
Determination of the HER2/neu (HER2) status in breast carcinoma has become necessary for the selection of breast cancer patients for trastuzumab therapy. Amplification of the gene analysed by fluorescence in situ hybridisation (FISH) or overexpressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f446eb80687d80db8d4afd565f2dc57c
https://serval.unil.ch/notice/serval:BIB_CAF148C59644
https://serval.unil.ch/notice/serval:BIB_CAF148C59644